Fox Run Management’s Calumet Specialty Products CLMT Stock Holding History

Fox Run Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-19,300	Closed	-$87K	–	525
2016 Q3	$87K	Buy	+19,300	New	+$99.3K	0.05%	451
2016 Q1	–	Sell	-10,500	Closed	-$209K	–	432
2015 Q4	$209K	Buy	+10,500	New	+$259K	0.16%	302

Other funds holding CLMT

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

SOAMC

Spirit of America Management Corp Syosset, New York $530M AUM 36.47% 1-Year Est. Return

Fox Run Management's CLMT Position: Q4 2016 in Review

Fox Run Management sold out of Calumet Specialty Products (CLMT) in Q4 2016, closing a stake of 19,300 shares — an estimated $87K sold.

Fox Run Management first reported a position in CLMT in Q4 2015 and held it in 2 quarters. The position peaked at $209K in Q4 2015. 81 funds tracked by Wall St. Rank hold CLMT as of Q4 2016.

Fox Run Management reported no remaining Calumet Specialty Products position as of Q4 2016 after selling out during the quarter.
Fox Run Management sold 19,300 Calumet Specialty Products shares in Q4 2016, an estimated $87K.
Fox Run Management first reported a position in Calumet Specialty Products in Q4 2015 and held it in 2 quarters.
Fox Run Management's Calumet Specialty Products position peaked at $209K in Q4 2015.
81 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2016.

Based on Fox Run Management's 13F filing for Q4 2016, filed 10 Jan 2017.